BINGO!

INDIANA — Jasper County 4-H members headed to 4-H camp in early June down at Shakamak State Park. The theme of the camp this year was Game On! and incorporated various popular games and board games. The campers were able to participate in eight different classes that included Animal Tracking…

Smiles of the Day




Current Weather

Right Now
61°
Partly Cloudy
  • Humidity: 84%
  • Cloud Coverage:27%
  • Wind: 1 mph
  • UV Index: 9 Very High
  • Sunrise: 05:18:44 AM
  • Sunset: 08:24:33 PM

Today

A mix of clouds and sun. High 81F. Winds N at 10 to 20 mph.

Tonight

A clear sky. Low 54F. Winds NNE at 10 to 15 mph.

Tomorrow

Mainly sunny. High 81F. Winds NNE at 5 to 10 mph.

Recent Obituaries

Follow us on Facebook


Special Sections Spotlight

INDIANA — Jasper County 4-H members headed to 4-H camp in early June down at Shakamak State Park. The theme of the camp this year was Game On! and incorporated various popular games and board …

Trending Food Videos

  • Updated

INDIANAPOLIS, June 15, 2021 /PRNewswire/ -- To advance the science of migraine treatment and aid the understanding of calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) compared to oral CGRP receptor antagonists in the prevention of migraine, Eli Lilly and Company (NYSE: LLY) will be conducting a head-to-head study comparing once-monthly injectable Emgality® (galcanezumab-gnlm) with Nurtec® ODT (rimegepant), an orally disintegrating tablet patients take every other day. CGRP is a protein in the brain thought to play a key role in migraine. Emgality binds to this protein, preventing it from attaching to the CGRP receptors, whereas Nurtec ODT blocks the receptor for this protein.1-3  This study aims to answer important questions that will help clinicians and patients make more informed treatment decisions on the path to more migraine-free days.